Introduction

Epilepsia

Volumn 52, Issue SUPPL. 3, 2011, Pages 1-4

  Vezzani, Annamaria ^a   Rüegg, Stephan ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPILEPSY; EPILEPTIC STATE; FEBRILE CONVULSION; IMMUNITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; SEIZURE; TEMPORAL LOBE EPILEPSY;

EID: 79955693598     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2011.03028.x     Document Type: Review

References (32)

1. Aarli JA,. (2000) Epilepsy and the immune system. Arch Neurol 57: 1689-1692.
2. Allan SM, Tyrrell PJ, Rothwell NJ,. (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5: 629-640. (Pubitemid 41113194)
3. Bianchi ME,. (2007) DAMPs, PAMPs and alarmins: we all need to know about danger. J Leukoc Biol 81: 1-5. (Pubitemid 46028489)
4. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H,. (2002) Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 51: 311-318. (Pubitemid 34206287)
5. Bien CG, Urbach H, Schramm J, Soeder BM, Becker AJ, Voltz R, Vincent A, Elger CE,. (2007) Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69: 1236-1244. (Pubitemid 47429024)
6. Bonati LH, Naegelin Y, Wieser HG, Fuhr P, Rüegg S,. (2006) Beta activity in status epilepticus. Epilepsia 47: 207-210.
7. Choi J, Nordli DR Jr, Alden TD, DiPatri A Jr, Laux L, Kelley K, Rosenow J, Schuele SU, Rajaram V, Koh S,. (2009) Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 6: 38.
8. Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR,. (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36. (Pubitemid 46214241)
9. Dinarello CA,. (2004) Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10: 201-222. (Pubitemid 39481010)
10. Dubé CM, Brewster AL, Richichi C, Zha Q, Baram TZ,. (2007) Fever, febrile seizures and epilepsy. Trends Neurosci 30: 490-496. (Pubitemid 47513235)
11. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH,. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
12. Heida JG, Moshé SL, Pittman QJ,. (2009) The role of interleukin-1beta in febrile seizures. Brain Dev 31: 388-393.
13. Irani S, Lang B,. (2008) Autoantibody-mediated disorders of the central nervous system. Autoimmunity 41: 55-65.
14. Jankowsky JL, Patterson PH,. (2001) The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol 63: 125-149.
15. Jiang J, Ganesh T, Du Y, Thepchatri P, Rojas A, Lewis I, Kurtkaya S, Li L, Qui M, Serrano G, Shaw R, Sun A, Dingledine R,. (2010) Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor. Proc Natl Acad Sci U S A 107: 2307-2312.
16. Kramer U, Sagi L, Goldberg-Stern H, Zelnik N, Nissenkorn A, Ben-Zeev B,. (2009) Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES). Epilepsia 50: 1517-1524.
17. Kulkarni SK, Dhir A,. (2009) Cyclooxygenase in epilepsy: from perception to application. Drugs Today 45: 135-154.
18. Low CL,. (1958) Infantile spasms with mental retardation. II. Treatment with cortisone and adrenocorticotropin. Pediatrics 22: 1165-1169.
19. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Binachi ME, Vezzani A,. (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16: 413-419.
20. Nguyen MD, Julien JP, Rivest S,. (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3: 216-227. (Pubitemid 135706591)
21. Palace J, Lang B,. (2000) Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry 69: 711-714.
22. Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM,. (2004) The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 45: 516-526. (Pubitemid 38581564)
23. Rasmussen T, Olszewsky J, Lloyd Smith D,. (1958) Focal seizures due to chronic localized encephalitis. Neurology 8: 435-445.
24. Riazi K, Galic MA, Pittman QJ,. (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89: 34-42.
25. Robakis TK, Hirsch LJ,. (2006) Literature review, case report, and expert discussion of prolonged refractory status epilepticus. Neurocrit Care 4: 35-46. (Pubitemid 43269460)
26. Shorvon S, Baulac M, Cross H, Trinka E, Walker M, TaskForce on Status Epilepticus of the ILAE Commission for European Affairs. (2008) The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 49: 1277-1285. (Pubitemid 351991403)
27. Vezzani A, Balosso S, Ravizza T,. (2008) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22: 797-803.
28. Vezzani A, French J, Bartfai T, Baram TZ,. (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.
29. Vincent A, Irani SR, Lang B,. (2010) The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins. Curr Opin Neurol 23: 144-150.
30. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D,. (2007) Treatment of pediatric epilepsy: European expert opinion. Epileptic Disord 9: 353-412. (Pubitemid 351147653)
31. Wirrell E, Farrell K, Whiting S,. (2005) The epileptic encephalopathies of infancy and childhood. Can J Neurol Sci 32: 409-418. (Pubitemid 41788898)
32. Wong SH, Saunders MD, Larner AJ, Das K, Hart IK,. (2010) An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatry 81: 1167-1169.